P53 Gene Mutations in Human Esophageal Cancer and Human Esophageal Tissues Treated with AMN

李利亚,唐劲天,刘轩,贾倞,周东辉,李佩文
DOI: https://doi.org/10.3969/j.issn.1673-5269.2004.04.004
2004-01-01
Abstract:OBJECTIVE:To characterize gene mutation in esophageal cancer and adjacent non-cancerous tissue and to study their roles in carcinogenesis.METHODS:Mutations of p53(exon 4-8) were analysed in 24 surgically resected human esophageal specimens from Linxien in Henan and 21 normal human esophagus maintained in the improved SCID(severe combined immunodeficient) mice treated or not with N-amyl-N-methylnitrosamine (AMN) by polymerase chain reaction (PCR) and single-strand conformation polymorphism(SSCP),and DNA sequencing.RESULTS:p53 gene mutations were predominantly detected in both esophageal cancer specimens(18 mutations) and adjacent non-cancerous tissues (10 mutations).G-A transition was predominant.Fourteen normal human esophagus continously treated with AMN induced cancerouschange(6 mutations),and G-A transition at codon 283 of p53 gene was detected in the lesion.CONCLUSIONS:The results suggest that p53 gene mutation is the same in esophageal cancer and adjacent non-cancerous tissues and environmental or endogenous nitrosamines may cause higher incidence of esophageal cancer at Linxian in He’nan,China.
What problem does this paper attempt to address?